YARROW BIOSCIENCE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
YARROW BIOSCIENCE, INC. (YARW) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $400.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-03.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2020-03-03
- YARROW BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2019-12-31 was $146.00K, a 942.86% increase year-over-year.
- YARROW BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2019-09-30 was $1.00K.
- YARROW BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2019-06-30 was $123.00K.
- YARROW BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2019-03-31 was $130.00K.
- YARROW BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2019 was $400.00K, a 77.78% decline from fiscal 2018.
- YARROW BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2018 was $1.80M, a 800.00% increase from fiscal 2017.
- YARROW BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2017 was $200.00K.
- YARROW BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2016 was $0.00.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month as first filed |
|---|---|---|---|---|---|
| 2019-12-31 | $146.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $147.00K derived: sum of 2 quarters · filed 2020-03-03 | $270.00K derived: sum of 3 quarters · filed 2020-03-03 | $400.00K 10-K · filed 2020-03-03 | |
| 2019-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $124.00K derived: sum of 2 quarters · filed 2019-10-31 | $254.00K 10-Q · filed 2019-10-31 | $268.00K derived: sum of 4 quarters · filed 2020-03-03 | |
| 2019-06-30 | $123.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $253.00K 10-Q · filed 2019-08-01 | $267.00K derived: sum of 3 quarters · filed 2020-03-03 | ||
| 2019-03-31 | $130.00K 10-Q · filed 2019-05-02 | $144.00K derived: sum of 2 quarters · filed 2020-03-03 | |||
| 2018-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $1.80M 10-K · filed 2020-03-03 | |||
| 2018-09-30 | $1.79M 10-Q · filed 2018-11-07 | ||||
| 2017-12-31 | $200.00K 10-K · filed 2020-03-03 | $209.00K 10-K · filed 2018-03-28 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-02-28 | ||||
| 2015-12-31 | $0.00 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |